FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula (I) , where A, B represent C; D is selected from N; X is selected from -CRaRb-, -O-; Y is selected from O; Z1 and Z2 are independently selected from hydrogen, substituted or unsubstituted alkyl having 1-8 atoms, R1-R4 are independently selected from hydrogen or halogen; R5-R16 independently represent hydrogen; where Ra and Rb independently represent hydrogen; n equals 1-3; m equals 0 or 1, k equals 2; or to pharmaceutically acceptable salts or solvates of the said compounds. The invention also relates to a pharmaceutical composition based on the said compounds which inhibits butyrylcholin esterase (BuChE).
EFFECT: obtaining novel compounds and a pharmaceutical composition based on the said compounds, which can be used for treating or preventing cognitive disorders and/or neurodegenerative disorders.
10 cl, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
TACRINE DERIVATIVES AS ACETYLCHOLINESTERASE INHIBITORS | 2004 |
|
RU2402545C2 |
FLAVONOID COMPOUNDS AND USE THEREOF | 2006 |
|
RU2431634C2 |
INHIBITORS OF TWO SITES OF BINDING ACETYLCHOLINESTERASE FOR TREATMENT OF THE ALZHEIMER'S DISEASE | 2003 |
|
RU2325379C2 |
NEW COMPOSITIONS FOR PREVENTING OR TREATING DEGENERATIVE DISEASES OF CENTRAL NERVOUS SYSTEM | 2010 |
|
RU2581058C2 |
MORPHINAN DERIVATIVE | 2016 |
|
RU2762567C2 |
TRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION INCLUDING IT, POSSESSING ANALGESIC ACTIVITY | 2011 |
|
RU2565073C2 |
PYRAZINO[1,2-A]INDOLE COMPOUNDS, PREPARATION AND USE THEREOF IN MEDICAMENTS | 2014 |
|
RU2660417C2 |
PYRAZOLE COMPOUNDS AS SIGMA RECEPTOR INHIBITORS | 2011 |
|
RU2582338C2 |
ANTITUMOUR COMPOUNDS | 2008 |
|
RU2493147C2 |
ARYL-SUBSTITUTED CARBOXAMIDE DERIVATIVES AS CALCIUM OR SODIUM CHANNEL BLOCKERS | 2010 |
|
RU2575168C2 |
Authors
Dates
2010-04-20—Published
2005-05-27—Filed